Tag:
jobs
Latest Headlines
Latest Headlines
Novartis, Lundbeck score wins for manufacturing in the West
Kudos to the Novartis ( $NVS ) ops team in Nyon, Switzerland! They've persuaded execs to keep open an OTC drug-making plant that the company had doomed to closure last fall. The company also has agreed
B.S., M.S. manufacturing jobs grow with R&D cutbacks
As the pharma industry compresses R&D, hiring managers are more often seeking candidates for manufacturing and operations jobs. Accompanying this shift is one toward candidates holding B.S. and
Novartis to cut 2,000 jobs in ops restructuring
Some 2,000 jobs, largely in Switzerland and the U.S, will give way to 700 new positions in India and China for Novartis ( $NVS ) in the coming 5-year period. Upside for the company: annual savings of
Dendreon deals body blow to manufacturing ops
Manufacturing takes the biggest hit as Dendreon ( $DNDN ) crashes back to earth. The formerly high-flying biotech announced late last week it's laying off a quarter of its workforce--500 of 2,000
Merck pushes pharma to top jobs-cutter
Merck ( $MRK ) has almost single-handedly snatched the top spot for monthly job cuts from the U.S. government, ending a 7-month streak by the public-sector behemoth. U.S. job cuts overall jumped a
PwC reports high pay, attrition at Indian pharmas
Pharmaceutical companies in India boast the second-highest average salary per employee compared with other industries surveyed, trailing only consumer goods. And drugmakers spend more on training per
Merck hiring may show FDA influence
The ZRG Partners global life sciences hiring index for the fourth quarter of 2010 shows a 12 percent increase in job postings for regulatory, quality and clinical jobs over Q3 figures; a 16 percent
Genzyme hiring push a hopeful sign for industry
The pharma operations job outlook may appear to remain bleak, given last week's news that GSK will divest two U.S. facilities, likely wiping out 460 manufacturing jobs. Add to that the recent
Sweet deal keeps Bayer in NJ
New Jersey officials, including Governor Chris Christie, have cheered Bayer HealthCare Pharmaceuticals' decision to consolidate operations in that state--a move that comes thanks in part to $35
Cut jobs not likely to reappear
Pharma's shift into emerging markets and away from established sales and marketing routines leads to permanent job cuts, says The Economist. That's in contrast to job cuts that normally accompany a
